Global AI-Enabled Drug Discovery and Clinical Trials Market | Key players are AiCure Ardigen Atomwise Inc. Benevolent AI Berg Berkeley Lights BioAge Labs Biovista C4X Discovery Holdings Plc Clinithink Ltd and many more.

The Market size of the Global AI-Enabled Drug Discovery and Clinical Trials market in the year 2021 is valued at 450.72 million and is predicted to reach 3641.01 million by the year 2030 at a 26.3% CAGR during the forecast period.

Curious about this latest version of report? Obtain Report Details @ https://www.insightaceanalytic.com/report/global-ai-enabled-drug-discovery-and-clinical-trials-market-/1239

AI-Enabled Drug Discovery and Clinical Trials are fundamental procedures primarily done by using artificial intelligence technology that has been gaining wide acceptance across the world. Increasing penetration of technology in the healthcare industry will further boost AI-Enabled Drug Discovery and Clinical Trials market potential in the long run. Digitization of the healthcare industry saw a significant boost in the COVID-19 pandemic, and this trend has created a lucrative setting for AI-Enabled Drug Discovery and Clinical Trials market growth throughout the forecast period.

Increasing support from the government and rising demand for rapid development of drugs is expected to boost AI-Enabled Drug Discovery and Clinical Trials market potential. Human rights concerns associated with clinical trials are also a factor that increases the adoption of AI in clinical trials and drug discovery as they reduce the risk to human health. However, the high costs of deployment and operation of AI-Enabled Drug Discovery and Clinical Trials are projected to have a hampering effect on the global AI-Enabled Drug Discovery and Clinical Trials market potential through 2030. The rising establishment of multiple healthcare research companies will also favour AI-Enabled Drug Discovery and Clinical Trials market potential throughout the forecast period.

List of Prominent Players in the AI-Enabled Drug Discovery and Clinical Trials Market:
Accutar Biotechnology Inc.
AiCure
Ardigen
Atomwise Inc.
Benevolent AI
Berg
Berkeley Lights
BioAge Labs
Biovista
C4X Discovery Holdings Plc
Clinithink Ltd
Cloud Pharmaceuticals
Cyclica Inc.
CytoReason
Concerto Health AI.
Deep Genomics Inc.
DeepThink Health Inc.
Envisagenics, Inc.
Exscientia Limited
e-therapeutics plc
GNS Healthcare
Insilico Medicine
Lantern Pharma Inc.
Medable, Inc.
Mind the Byte
NuMedii, Inc
Nuritas, Ltd.
Owkin, Inc.
Recursion Pharmaceuticals, Inc.
Schrödinger, LLC
Symphony Innovation, LLC
TARA Biosystems, Inc.
twoXAR, Incorporated
Verge Analytics, Inc.
Winterlight Labs Inc.
WuXi Nextcode Genomics
XtalPi Inc.
Other Prominent Players

For More Information @ https://www.insightaceanalytic.com/report/global-ai-enabled-drug-discovery-and-clinical-trials-market-/1239

Market Dynamics:
Drivers:
The increasing prevalence of chronic diseases and augmented demand for better healthcare services is expected to drive AI-Enabled Drug Discovery and Clinical Trials market growth. Other factors such as increasing incidence of chronic diseases, rising research activity, growing support from the government, high healthcare expenditure, etc., are also expected to crucially sculpt AI-Enabled Drug Discovery and Clinical Trials market growth over the forecast period. The increasing digitization of the healthcare industry is also expected to drive AI-Enabled Drug Discovery and Clinical Trials market growth in the coming years.

Challenges:
The major challenge for AI-Enabled Drug Discovery and Clinical Trials market is to manage the deployment and operations cost of these new systems that will be very complex to use and maintain. The absence of a skilled workforce for the same is also anticipated to hinder the adoption of AI-Enabled Drug Discovery and Clinical Trials systems across the world. The companies in the AI-Enabled Drug Discovery and Clinical Trials market are expected to work on these challenges to unlock full growth potential over the coming years.

Regional Trends:
North America holds a considerable proportion of the global market for AI-Enabled Drug Discovery and Clinical Trials due to its quick adoption of innovative technology. This region's market potential for AI-Enabled Drug Discovery and Clinical Trials will be driven through 2030 by the presence of developed healthcare infrastructure, a high level of healthcare research activity, and supporting government efforts. The United States is likely to be a very lucrative market in this area due to the increasing frequency of cancer and the necessity for earlier treatment. Additionally, high healthcare expenditures will play a significant function in this industry. The ageing population will also fuel the market potential for AI-Enabled Drug Discovery and Clinical Trials in the next years.

Recent Developments:
In May 2022, Standigm announced that it would be eyeing using its expertise to find a treatment for Crohn's disease. With the help of AI, the company plans to produce new compounds to test for their treatment effects on multiple patients.

AI-Enabled Drug Discovery and Clinical Trials Market Segmentation:
AI-Enabled Drug Discovery and Clinical Trials Market Segmentation: By Component Estimates & Trend Analysis
• Solutions
• Services

AI-Enabled Drug Discovery and Clinical Trials Market Segmentation: By Application Estimates & Trend Analysis
• Data Aggregation and Analysis
• Clinical Trials
• Drug Design
• Drug Characterization
• Biomarker Research

AI-Enabled Drug Discovery and Clinical Trials Market Segmentation: By Therapeutic Application Estimates & Trend Analysis
• Oncology
• Cardiovascular Diseases
• Nervous System Diseases
• Respiratory Disorder
• Metabolic Diseases
• Immunologic Diseases
• Infectious Diseases

AI-Enabled Drug Discovery and Clinical Trials Market Segmentation: By End-user Estimates & Trend Analysis
• Biopharmaceutical Industry
• Contract Research Organizations (CROs)
• Academic Institutes and Research Centers

Request for ToC/Proposal: https://www.insightaceanalytic.com/request-sample/1239

InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.